# DT Capital Partners

> DT Capital Partners is a VC fund in Shanghai backing Health Care and Medical. See 142 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 142
- Last investment: Jul 2026
- Lead investor: 28%
- Fund size: $277M
- Last fund: Dec 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/detong-capital/
- Website: http://www.dtcap.com/cn/home.asp

DT Capital Partners is a private equity investment firm that provides growth capital to early and expansion stage companies. They invest in dynamic businesses that have high growth potential, strong management teams, and demonstrated revenue models in both technology-based and traditional industries. DT Capital Partners currently manages overUSD$500 Million in capital across multiple US dollar and RMB funds, and also has a close affiliation with Madrone Capital in the US, the investment entity for members of the Walton family.In addition to funds, the invested company also benefits from their extensive experience in operating capital markets across the country, close relationships with local governments and companies, and synergies with other investment companies.DT Capital Partners was awarded the “Top 10 China's Best Return Venture Capital Institution” in 2016, and the founding partners of Detong Capital, Shao Jun and Tian Lixin. DT Capital Partner was founded in 2006 and is based in Shanghai, China.

## Contacts

5 contacts available for DT Capital Partners. Shizune tracks 9 team members at DT Capital Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/dt-capital-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.4M–$31M |
| Series B | $2.8M–$90M |
| Series C | $15M–$102M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 16 | 11% |
| Medical | 15 | 11% |
| Biotechnology | 12 | 8% |
| Software | 11 | 8% |
| Manufacturing | 11 | 8% |

143 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 46 | 32% |
| Series B | 27 | 19% |
| Series C | 13 | 9% |
| Funding Round | 10 | 7% |
| Seed | 9 | 6% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 98 | 69% |
| United States | 7 | 5% |
| South Korea | 2 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chirs Bian | Analyst | 0 | https://shizune.co/investors/profile/chirs-bian |
| Daniel Lu | Operation Partner | 0 | https://shizune.co/investors/profile/daniel-lu |
| Jason Xu | Partner | 0 | https://shizune.co/investors/profile/jason-xu-2 |
| Jenny Yu | Analyst | 0 | https://shizune.co/investors/profile/jenny-yu |
| Kelvin Zhen | Analyst | 0 | https://shizune.co/investors/profile/kelvin-zhen |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Villanelle Life | Villanelle Life is a biotechnology company that specializes in creating AI drugs, early screening, and auxiliary diagnosis platforms to solve complex diseases. |  | Seed | Jul 16, 2026 |  |
| Mojie | Mojie is a technology company that engages in the research and development of optics and AI solutions, known for its extensive development of various core technologies. The company operates research and development offices and high-end manufacturing bases. | $88.5M | Series A | Jul 13, 2026 |  |
| Drug Farm | Drug Farm is a China and US-based biotech developing innovative treatments targeting innate immunity for HBV, cancer, and autoimmune diseases. Drug Farm's unique IDInVivo platform combines breakthrough technologies in genetics and AI to discover new treatments. | $55M | Series D | Jul 13, 2026 |  |
| Linkai Semiconductor | Linkai Semiconductor designs non-volatile memory and AI storage chips using proprietary ATopFlash© and HBF+ architectures. The company develops high-bandwidth, low-power storage hardware compatible with HBM ecosystems specifically for large-model AI inference scenarios. |  | Seed | Jul 03, 2026 |  |
| Matrix Optoelectronics Technology | Matrix Optoelectronics is a quantum computing technology developer that specializes in the research and development of large-scale fault-tolerant superconducting quantum computing technology. | $29.4M | Angel | May 18, 2026 |  |
| CiMicro.Ai | CiMicro.ai is an AI‑chip startup building compute‑in‑memory (CiM)‑based heterogeneous accelerators for high‑efficiency, low‑cost large‑language‑model inference. | $14.7M | Seed | May 07, 2026 |  |
| Linkerbot | Lingxin Qiaoshou focuses on the research and development and production of embodied intelligent platforms with "dexterous hands + cloud-based intelligent brain" as the core. |  | Series B | Apr 29, 2026 |  |
| Dongli Retirement Club | Dongli Retirement Club is a social and entertainment platform tailored for retirees, offering comprehensive services like travel, gatherings, merchandise, and hobbies to keep active seniors aged 50-80 engaged. | $14.7M | Series B | Apr 20, 2026 |  |
| Matrix Optoelectronics Technology | Matrix Optoelectronics is a quantum computing technology developer that specializes in the research and development of large-scale fault-tolerant superconducting quantum computing technology. |  | Seed | Apr 08, 2026 |  |
| Guoshun Laser | Guoshun Laser is a developer of high-power ultrafast micro-nano structure fiber lasers. |  | Series A | Mar 17, 2026 |  |

10 of 142 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 6 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 5 deals together
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 5 deals together
- [Zhencheng Capital](https://shizune.co/investors/profile/zhencheng-capital) — VC Fund, 5 deals together
- [Northern Light Venture Capital](https://shizune.co/investors/profile/northern-light-venture-capital) — VC Fund, 4 deals together
- [Oriental Fortune Capital](https://shizune.co/investors/profile/oriental-fortune-capital) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [Warner Music Group](https://shizune.co/investors/profile/warner-music-group) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Goodwater Capital](https://shizune.co/investors/profile/goodwater-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [All Investors in China](https://shizune.co/investors/investors-china)
- [All VC Funds in China](https://shizune.co/investors/vc-funds-china)
- [SaaS Investors in China](https://shizune.co/investors/saas-investors-china)
- [SaaS VC Funds in China](https://shizune.co/investors/saas-vc-funds-china)
- [Enterprise Investors in China](https://shizune.co/investors/enterprise-investors-china)
- [Enterprise VC Funds in China](https://shizune.co/investors/enterprise-vc-funds-china)

## FAQ

### What does DT Capital Partners invest in?

DT Capital Partners invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 142 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is DT Capital Partners's check size?

DT Capital Partners typically joins rounds of $1.4M–$31M at Series A, $2.8M–$90M at Series B and $15M–$102M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds DT Capital Partners participates in.

### How do I contact DT Capital Partners?

Public channels for DT Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at DT Capital Partners?

The team at DT Capital Partners includes Chirs Bian (Analyst), Daniel Lu (Operation Partner) and Jason Xu (Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co